E-13R

N/A

Report date: 2023/05/22 10:17:32

Base Information

Drug NameE-13R
Drug Alias NameE13R
ClassificationSmall molecules
Mechanisms of ActionInterleukin-5 receptors inhibitors
TargetsInterleukin-5 receptors
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHospira Adelaide Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHospira Adelaide Pty Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A